Clinical Trial Update: Qualitative Effects of AEF0217 in Down Syndrome People

View source ↗

Summary

An ongoing study assessing qualitative effects of the experimental drug AEF0217 in people with Down syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• AEF0217

Snippet

Sponsor: Aelis Farma | Conditions: Down Syndrome (Trisomy 21) | Status: ENROLLING_BY_INVITATION